Form 4 for BDSX BIODESIX INC
Accepted 2023-01-05 00:00:00 ET · period of report 2022-11-21 · accession 0001140361-23-000723 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-01-05 | 2022-11-21 | BDSX | Kennedy Lawrence T. Jr | 10% | P - Purchase | $1.15 | +10.87M | 4.36M | New | +$12.50M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-21 | P | A | 8,260,869 | $1.15 | 9,148,889 | I By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 | — | — | (F1) Reported amounts have been adjusted to reflect the September 27, 2022 transfer of 469,026 shares previously held by the Lair BDSX GRAT 2022-3.2 to the Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act. |
| 2 | Common | Common Stock | 2022-11-21 | P | A | 2,608,696 | $1.15 | 4,355,914 | I By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 | — | — |